Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Join
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Join
FREE
Pharma News, Views & Analysis
Filter
News
Articles
Podcasts
Infographics
Advertise With Us
Advertise With Us
Philips’ Dr Carla Goulart Peron on AI, equity and the future of care
How can AI expand healthcare access without losing the human touch? Philips’ CMO Dr Carla Goulart Peron shares all.
Read more
Should pharma tune into the ‘earfluence’ of the podcast?
As podcasts become a popular medium for learning and knowledge sharing, should the pharmaceutical industry give them a go as a way to educate patients and healthcare professionals?
Lifting the curtain on patient data
How can the pharmaceutical industry lead the way in data transparency and give more patients the confidence to share their records with researchers?
So long to the sales rep? Pharma sales is changing
It has become clear that healthcare professionals don’t want to be sold to. They want to be partners with industry and be treated as such. How can the rep model evolve to stay in line with expectations?
A proactive approach to patient centricity
The increasing focus on patient centricity in recent years has ensured pharmaceutical companies are far more in sync with the issues that patients’ face on a day-to-day basis than ever before; however, translating these insights into treatment improvements remains a challenge.
An entrepreneurial approach to R&D
Decline in R&D productivity levels is rapidly becoming one of the biggest challenges for the pharmaceutical industry, but what can it do?
Amgen’s Victoria Elegant on driving innovation through diversity and inclusion
Victoria Elegant, Vice President and Region Head of Medical, Amgen, shares insights on the importance of diversity in delivering innovation, pharma in the JAPAC region and what medical affairs teams across the globe can learn from China.
Lead us on, medical affairs
Perfectly positioned to bridge the gap between R&D and commercial, MA must seize their strategic position within the industry to guide the future of the function.
Innovate to elevate HCP engagement
The regulatory ecosystem of the pharmaceutical industry and people’s decreasing attention spans is proving a complex reality for marketers that has provided an imperative to innovate.
Loading posts...
« Previous
1
…
30
31
32
33
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View